tiprankstipranks
Trending News
More News >
EssilorLuxottica SA (ESLOY)
OTHER OTC:ESLOY

EssilorLuxottica SA (ESLOY) Price & Analysis

Compare
192 Followers

ESLOY Stock Chart & Stats

$159.07
-$0.84(-0.69%)
At close: 4:00 PM EST
$159.07
-$0.84(-0.69%)

Bulls Say, Bears Say

Bulls Say
Sustained Revenue GrowthMulti-year top-line expansion and broad regional acceleration indicate durable end-market demand for lenses and branded eyewear. Consistent revenue growth supports scale benefits, stronger negotiating leverage with suppliers, and the ability to fund strategic R&D and retail investments over the medium term.
Strong Cash GenerationHigh and improving cash flow provides lasting financial flexibility to fund R&D, capex for wearables/Med‑Tech, and M&A without overreliance on equity issuance. Even with moderate cash conversion, persistent positive free cash flow supports investment cycles and de-risks execution on long-term initiatives.
Brand, Product & Med‑tech LeadershipLeading global brands, rapid AI wearables adoption and FDA‑authorized myopia products create structural competitive advantages. These assets deepen customer relationships, enable premium pricing and recurring clinical services, and position the company to capture long-term market share in both consumer and medical segments.
Bears Say
Rising LeverageMeaningful debt increase reduces balance sheet flexibility and raises sensitivity to higher interest rates. Sustained leverage at elevated levels can restrict capital allocation choices, increase financing costs over time, and heighten downside risk if revenue or margin recovery is slower than planned.
Gross Margin CompressionRapid growth in lower‑margin AI wearables and one‑time tariffs materially compressed gross margins. If the high‑growth product mix or trade costs persist before scale or price recovery, operating profitability will remain pressured and margin normalization may take several quarters to years.
Persistent FX, Tariff & Financing HeadwindsCombined tariff, currency and rising financing costs create structural earnings volatility. These macro and policy-driven headwinds can erode operating leverage and cash flow predictability, forcing more conservative investment pacing and compressing medium‑term net margin recovery.

EssilorLuxottica SA News

ESLOY FAQ

What was EssilorLuxottica SA’s price range in the past 12 months?
EssilorLuxottica SA lowest stock price was $127.19 and its highest was $186.18 in the past 12 months.
    What is EssilorLuxottica SA’s market cap?
    EssilorLuxottica SA’s market cap is $128.28B.
      When is EssilorLuxottica SA’s upcoming earnings report date?
      EssilorLuxottica SA’s upcoming earnings report date is Jul 24, 2026 which is in 152 days.
        How were EssilorLuxottica SA’s earnings last quarter?
        EssilorLuxottica SA released its earnings results on Feb 11, 2026. The company reported $1.729 earnings per share for the quarter, beating the consensus estimate of $1.573 by $0.156.
          Is EssilorLuxottica SA overvalued?
          According to Wall Street analysts EssilorLuxottica SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does EssilorLuxottica SA pay dividends?
            EssilorLuxottica SA pays a Annually dividend of $2.25 which represents an annual dividend yield of 1.41%. See more information on EssilorLuxottica SA dividends here
              What is EssilorLuxottica SA’s EPS estimate?
              EssilorLuxottica SA’s EPS estimate is 1.94.
                How many shares outstanding does EssilorLuxottica SA have?
                EssilorLuxottica SA has 926,579,160 shares outstanding.
                  What happened to EssilorLuxottica SA’s price movement after its last earnings report?
                  EssilorLuxottica SA reported an EPS of $1.729 in its last earnings report, beating expectations of $1.573. Following the earnings report the stock price went down -0.344%.
                    Which hedge fund is a major shareholder of EssilorLuxottica SA?
                    Currently, no hedge funds are holding shares in ESLOY
                    What is the TipRanks Smart Score and how is it calculated?
                    Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                      Company Description

                      EssilorLuxottica SA

                      EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in North America, Europe, Latin America, Asia, Oceania, and Africa. It operates in five segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The Wholesale segment engages in the manufacture and wholesale distribution of luxury and sports eyewear. The Retail segment retails luxury and sports eyewear. The Lenses and Optical Instruments segment offers lenses and small equipment, including Varilux progressive lenses; Crizal antireflective, anti-smudge, and antistatic lenses; Transitions photochromic lenses; Eyezen lenses for users of computers, tablets, smartphones, and other connected devices; Xperio polarized sun lenses; and Nikon and Kodak corrective lens brands. It also provides lens edging and mounting instruments for opticians and prescription laboratories; optometry instruments for eye care professionals, schools, occupational medicine centers, military, and other institutions; and Transitions Signature Gen 8 photochromic lens, as well as develops solutions for online sales of optical products. The Equipment segment offers digital surfacing machines and lens coating machines to prescription laboratories, integrated optical chains, and lens manufacturers. The Sunglasses and Readers segment provides non-prescription sunglasses and reading glasses under the Foster Grant, Gargoyles, Magnivision, Corinne McCormack, Monkey Monkey, Ryders Eyewear, and SolarShield brands; Reebok, Steve Madden, Betsey Johnson, Nine West, Dockers, French Connection, Ironman, Rawlings, Bodyglove, Panama Jack, Marvel, and Disney; Bolon, Molsion, Qina, and Prosun brands; and Mujosh and Aojo brands. It has a network of 490 prescription laboratories and edging-mounting facilities. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.

                      EssilorLuxottica SA (ESLOY) Earnings & Revenues

                      ESLOY Company Deck

                      ESLOY Earnings Call

                      Q4 2026
                      0:00 / 0:00
                      Earnings Call Sentiment|Positive
                      The call presents a strongly positive operational and commercial momentum — record revenue growth, record free cash flow, fast consumer adoption of AI glasses and clear progress in myopia management (including FDA authorization) and geographic expansion. These positives are tempered by near-term margin pressure driven by tariffs, unfavorable FX, higher interest costs and product‑mix dilution from the high growth of lower-margin wearables and upfront investment. Management expects scale, price/mix improvements and product evolution to drive margin recovery over the medium term and reaffirmed a 5-year outlook aligned for revenue and operating profit growth.View all ESLOY earnings summaries
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      DENTSPLY SIRONA
                      Warby Parker
                      Bausch + Lomb Corporation

                      Ownership Overview

                      <0.01%<0.01%99.96%
                      Insiders
                      <0.01% Other Institutional Investors
                      99.96% Public Companies and
                      Individual Investors

                      Options Prices

                      Currently, No data available
                      ---
                      Popular Stocks